Research location
Boys Town
Nebraska, United States
Advertisement
Research activity in Boys Town
Nebraska, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Boys Town
10 linked trials · page 1 of 1A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaNCT03052725 · 2017-03-10 · 1 site observation
TERMINATED
Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsNCT02452190 · 2015-09-28 · 1 site observation
COMPLETED
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaNCT01290887 · 2011-06-01 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaNCT01287039 · 2011-04-01 · 1 site observation
COMPLETED
A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingNCT01218009 · 2010-10-01 · 1 site observation
TERMINATED
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma INCT01172808 · 2010-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate AsthmaNCT01122680 · 2010-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Different Doses of IndacaterolNCT01079130 · 2010-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseNCT00846586 · 2009-03-01 · 1 site observation
COMPLETED
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)NCT00772538 · 2008-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.